✦ LIBER ✦

The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin

✍ Scribed by J. E. Tooke; L. M. Elston; K. M. Gooding; C. I. Ball; D. M. Mawson; J. Piper; R. Sriraman; R. Urquhart; A. C. Shore

Publisher: Springer
Year: 2006
Tongue: English
Weight: 114 KB
Volume: 49
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-006-0168-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The course of kidney function in Type 2

The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy

✍ M. -A. Gall; F. S. Nielsen; U. M. Smidt; H. -H. Parving 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 851 KB

The effect of sensitisation to insulin w

The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients

✍ K. Al Majali; M. B. Cooper; B. Staels; G. Luc; M-R. Taskinen; D. J. Betteridge 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 223 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

The effect of low-dose dopamine on renal

The effect of low-dose dopamine on renal haemodynamics in patients with type 1 (insulin-dependent) diabetes does not differ from normal individuals

✍ P. M. ter Wee; E. van Ballegooie; J. B. Rosman; S. Meijer; A. J. M. Donker 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 478 KB

Insulin resistance in Type 2 (non-insuli

Insulin resistance in Type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle

✍ J. Eriksson; L. Koranyi; R. Bourey; C. Schalin-Jäntti; E. Widén; M. Mueckler; A. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 769 KB

Therapy conversion to insulin detemir am

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: A modeling study of cost-effectiveness in the United States

✍ William J. Valentine; K. M. Erny-Albrecht; J. A. Ray; S. Roze; D. Cobden; A. J. 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB